565.  Newman, J.W., J.E. Stok, J.D. Vidal, C.J. Corbin, Q. Huang, B.D. Hammock and A.J. Conley.  2004.  Cytochrome P450-dependent lipid metabolism in preovulatory follicles.  Endocrinology.  145:5097-5105. [Download]

571.  Sellers, K.W., C. Sun, C. Diez-Freire, H. Waki, C. Morisseau, J.R. Falck, B.D. Hammock, J.F. Paton and M.K. Raizada.  2005.  Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat.  FASEB J.  19:626-628. [Download]

576.  Kim, I.-H., F.R. Heirtzler, C. Morisseau, K. Nishi, H.-J. Tsai and B.D. Hammock.  2005.  Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.  J. Med. Chem.  48:3621-3629. [Download]

577.  Aronov, P.A., K. Dettmer, J.A. Christiansen, A.J. Cornel and B.D. Hammock.  2005.  Development of a HPLC/tandem-MS method for the analysis of the larvicides methoprene, hydroprene and kinoprene at trace levels using Diels-Alder derivatization.  J. Agric. Food Chem.  53:3306-3312. [Download]

578  Nithipatikom, K., M.P. Endsley, M.A. Isbell, C.E. Wheelock, B.D. Hammock and W.B. Campbell.  2005.  A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer.  Biochem. Bioph. Res. Co.  332:1028-1033. [Download]

579.  Jones, P.D., N.M. Wolf, C. Morisseau, P. Whetstone, B. Hock and B.D. Hammock.  2005.  Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.  Anal. Biochem.  343:66-75. [Download]

580.  Fang, X., S. Hu, T. Watanabe, N.L. Weintraub, G.D. Snyder, J. Yao, Y. Liu, J. Y.-J. Shyy, B.D. Hammock and A.A. Spector.  2005.  Activation of peroxisome proliferators-activated receptor a by substituted urea-derived soluble epoxide hydrolase inhibitors. J. Pharmacol. Exp. Ther. 314:260-270. [Download]

581.  Schmelzer, K.R., L. Kubala, J.W. Newman, I.-H. Kim, J.P. Eiserich and B.D. Hammock.  2005.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation.  Proc. Natl. Acad. Sci. USA. 102(28):9772-9777. PMCID:PMC 1168955. [Download]

583.  Kang, K.-D., P.D. Jones, H. Huang, R. Zhang, L.A. Mostovich, C.E. Wheelock, T. Watanabe, L.F. Gulyaeva and B.D. Hammock.  2005.  Evaluation of a-cyano ethers as fluorescent substrates for assay of cytochrome P450 enyzme activity.  Anal. Biochem.  344:183-192. PMCID: PMC1450254. [Download]

584.  Wheelock, C.E., K. J. Eder, I. Werner, H. Huang, P.D. Jones, B.F. Brammell, A.A. Elskus and B.D. Hammock.  2005.  Individual variability in esterase activity and CYP1A levels in Chinook salmon (Oncorhynchus tshawytscha) exposed to esfenvalerate and chlorpyrifos.  Aquat. Toxicol.  74:172-192. PMCID: PMC1444896. [Download]

585.  German, J.B., B.D. Hammock and S.M. Watkins. 2005. Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1:3-9. PMCID:PMC1457093. [Download]

587.  Tran, K.L., P.A. Aronov, H. Tanaka, J.W. Newman, B.D. Hammock and C. Morisseau.  2005.  Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase.  Biochemistry-US.  44:12179-12187. PMCID: PMC1473036. [Download]

589.  Liu, Y., Y. Zhang, K. Schmelzer, T.-S. Lee, X. Fang, Y. Zhu, A.A. Spector, S. Gill, C. Morisseau, B.D. Hammock and J.Y-J. Shyy. 2005. The anti-inflammatory effect of laminar flow:  The role of PPAR?, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci.  102:16747-16752. PMCID:PMC 1276614. [Download]

590.  Vriens, J., G. Owsianik, B. Fisslthaler, M. Suzuki, A. Janssens, T. Voets, C. Morisseau, B.D. Hammock, I. Fleming, R. Busse and B. Nilius. 2005. Modulation of the Ca2+ permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res. 97:908-915. PMCID: PMC1276614. [Download]

594. Dorrance, A.M., N. Rupp, D.M. Pollock,J.W. Newman, B.D. Hammock and J.D. Imig. 2005. An epoxide hydrolase inhibitor, 12-(3-Adamantan-1-yl-ureido) dodecanoic acid (AUDA) reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharm. 46:842-848.PMCID: PMC1444897. [Download]

597.  Gomez, G.A., C. Morisseau, B.D. Hammock and D.W. Christianson.  2006.  Human soluble epoxide hydrolase:  structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.  Protein Sci.  15:58-64. PMCID: PMC1762130. [Download]

598.  Imig, J.D., X. Zhao, C.Z. Zaharis, J.J. Olearczyk, D.M. Pollock, J.W. Newman, I.-H. Kim, T. Watanabe and B.D. Hammock.  2005.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.  Hypertension.  46:975-981. PMCID: PMC1444888. [Download]

600.  Watanabe, T., D. Schulz, C. Morisseau and B.D. Hammock.  2006.  High-throughput pharmacokinetic method:  cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis.  Anal. Chimica Acta.  559:37-44. PMCID: PMC1447531. [Download]

601.  Huang, H., K. Nishi, S.J. Gee and B.D. Hammock.  2006.  Evaluation of chiral ?-cyanoesters as general fluorescent substrates for screening enantioeselective esterases.  J. Agr. Food Chem.  54:694-699. [Download]

602.  Shearer, G.C., J.W. Newman, B.D. Hammock and G.A. Kaysen.  2005.  Graded effects of proteinuria on HDL structure in nephrotic rats.  J. Am. Soc. Nephrol.  16:1309-1319. PMCID: PMC1444886. [Download]

604.  Davis, B.B., C. Morisseau, J.W. Newman, T.L. Pedersen, B.D. Hammock and R.H. Weiss.  2006.  Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.  J. Pharmacol. Exp. Ther.  316:815-821. PMCID: PMC1456012. [Download]

605.  Harris, T.R., C. Morisseau, R.L. Walzem, S.J. Ma and B.D. Hammock.  2006.  The cloning and characterization of a soluble epoxide hydrolase in chicken.  Poultry Sci.  85:278-287. PMCID: PMC1764503. [Download]

607.  Larsen, B.T., H. Miura, O.A. Hatoum, W.B. Campbell, B.D. Hammock, D.C. Zeldin, J.R. Falck and D.D. Gutterman.  2006.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels:  implications of soluble epoxide hydrolase inhibition.  Am J Physiol Heart Circ Physiol. 290:491-499. PMCID: PMC 1456013. [Download]

612.  Lee, C.R., K.E. North, M.S. Bray, M. Fornage, J.M. Seubert, J.W. Newman, B.D. Hammock, D.J. Couper, G. Heiss and D.C. Zeldin.  2006.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease:  The atherosclerosis risk in communities (ARIC) study.  Hum. Mol. Genet.  15:1640-1649. PMCID: PMC2040335. [Download]

614.  Carkeet, C., S.R. Dueker, J. Lango, B.A. Buchholz, J.W. Miller, R. Green, B.D. Hammock, J.R. Roth and P.J. Anderson. 2006. Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled 14C-cobalamin. Proc Natl Acad Sci U S A. 103(15):5694-99. PMID: 16585531. PMCID: PMC1458635. [Download]

616.  Wolf, N.M., C. Morisseau, P.D. Jones, B. Hock and B.D. Hammock. 2006. Development of a high throughput screen for soluble epoxide hydrolase inhibition. Anal Biochem. 355:71-80. PMCID: PMC1965403. [Download]

617.  Zhao, B., D.S. Baston, B.D. Hammock and M.S. Denison. 2006. Interaction of diuron and related substituted phenylureas with the Ah receptor pathway. J Biochem Molec Toxicol. 20:103-113. PMCID: PMC3032054. [Download]

618.  Li, H.-Y., Y. Jin, C. Morisseau, B.D. Hammock and Y.-Q. Long. 2006. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase. ioorg Med Chem. 14:6586-6592. PMCID: PMC2040075. [Download]

619.  Pokreisz, P., I. Fleming, L. Kiss, E. Barbosa-Sicard, B. Fisslthaler, J.R. Falck, B.D. Hammock, I.-H. Kim, Z. Szelid, P. Vermeersch, H. Gillijns, M. Pellens, F. Grimminger, A.-J. van Zonneveld, D. Collen, R. Busse and S. Janssens. 2006. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.  Hypertension.  47:762-770. PMCID: PMC1993904. [Download]

620. Olearczyk, J.J., M.B. Field,  I.-H. Kim, C. Morisseau, B.D. Hammock and J.D. Imig. 2006. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels. J Pharmacol Exp Ther. 318(3):1307-1314. PMCID: PMC1892247. [Download]

621. Seubert, J.M., C.J. Sinal, J. Graves, L.M. DeGraff, J.A. Bradbury, C.R. Lee, K. Goralski, M.A. Carey, A. Luria, J.W. Newman, B.D. Hammock, J.R. Falck, H. Roberts, H.A. Rockman, E. Murphy and D.C. Zeldin. 2006. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ. Res.  99:442-450. PMCID: PMC2072806. [Download]

622.  Jones, P.D., H.-J. Tsai, Z.N. Do, C. Morisseau and B.D. Hammock. 2006. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 16:5212-5216. PMCID: PMC1904344. [Download]

623.  Schmelzer, K.R., A.M. Wheelock, K. Dettmer, D. Morin and B.D. Hammock. 2006. The role of inflammatory mediators in the synergistic toxicity of ozone and 1-nitronaphthalene in rat airways. Environ Health Persp. 114:1354-1360. PMCID: PMC1570074. [Download]

624.  Schmelzer, K.R., B. Inceoglu, L. Kubala, I.-H. Kim, S.L. Jinks, J.P. Eiserich and B.D. Hammock. 2006. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA. 103:13646-13651. PMCID: PMC1564210. [Download]

625.  Morisseau, C., J.W. Newman, H.J. Tsai, P.A. Baecker and B.D. Hammock.  2006. Peptidyl-urea based inhibitors of soluble epoxide hydrolases. Bioorg Med Chem Lett. 16:5439-5444. PMCID: PMC1892215. [Download]

627.  Hwang, S.H., C. Morisseau, Z. Do and B.D. Hammock. 2006. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors. Bioorg Med Chem. 16:5773-5777. PMCID: PMC1904340. [Download]

628.  Ng, V.Y., C. Morisseau, J.R. Falck, B.D. Hammock and D.L. Kroetz. 2006. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor ?-dependent repression of Cyclin D1. Arterioscl. Throm. Vas. 26:2462-2468. PMCID: PMC1904341. [Download]

629.  Inceoglu, B., S.L. Jinks, K.R. Schmelzer, T. Waite, I.-H. Kim and B.D. Hammock. 2006. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci. 79:2311-2319. PMCID: PMC1904345. [Download]

630.  Xu, D., N. Li, Y. He, V. Timofeyev, L. Lu, H.-J. Tsai, I.-H. Kim, D. Tuteja, R.K.P. Mateo, A. Singapuri, B. Davis, R. Low, B.D. Hammock and Nipavan Chiamvimonvat. 2006. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA.  103:18733-18738. PMCID: PMC1693731. [Download]

631.  Kim, I.-H., K. Nishi, H.-J. Tsai, T. Bradford, Y. Koda, T. Watanabe, C. Morisseau, J. Blanchfield, I. Toth and B.D. Hammock. 2007. Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido) dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem.  15:312-323. PMCID: PMC2040326. [Download]

632. Dettmer, K., P.A. Aronov and B.D. Hammock. 2007. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26(1):51-78. PMID: 16921475. PMCID: PMC1904337. [Download]

633. Inceoglu, B., K.R. Schmelzer, C. Morisseau, S.L. Jinks and B.D. Hammock.  2007. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat.  82:42-49. PMCID: PMC1904338. [Download]

636.  Luria, A., S.M. Weldon, A.K. Kabcenell, R.H. Ingraham, D. Matera, H. Jiang, R. Gill, C. Morisseau, J.W. Newman, B.D. Hammock. 2007. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem. 282:2891-2898. PMCID: PMC2040337. [Download]

637.  Chiappe, C., E. Leandri, B.D. Hammock and C. Morisseau. 2007. Effect of ionic liquids on epoxide hydrolase-catalyzed synthesis of chiral 1,2-diols.  Green Chem. 9:162-168. PMCID: PMC2153531. [Download]

638.  Loch, D., A. Hoey, C. Morisseau, B. Hammock and L. Brown. 2007. Prevention of hypertension in DOCA-salt rats by an inhibition of soluble epoxide hydrolase. Cell Biochem Biophys. 47:87-97. PMCID: PMC1892223.. [Download]

641.  Akatsuka, T., N. Kobayashi, T. Ishikawa, T. Saito, M. Shindo, M. Yamauchi, K. Kurokohchi, H. Miyazawa, H. Duan, T. Matsunaga, T. Komoda, C. Morisseau and B.D. Hammock. 2007. Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J Autoimmun.  28:7-18. PMCID: PMC1892246. [Download]

644. Thompson, D.A. and B.D. Hammock. 2007. Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst.  J Biosci. 32:279-291. PMCID: PMC1904342. [Download]

645.  Zhang, W., I.P. Koerner, R. Noppens, M. Grafe, H.J. Tsai, C. Morisseau, A. Luria, B.D. Hammock, J.R. Falck and N. Alkayed. 2007. Soluble epoxide hydrolase: A novel therapeutic target in stroke. J Cereb Blood Flow Metab.  27(12):1931-40. PMCID: PMC2664093. [Download]

646. Ai, D., Y. Fu, D. Guo, H. Tanaka, N. Wang, C. Tang, B.D. Hammock, J.Y-J. Shyy and Y. Zhu. 2007. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci USA. 104:9018-9023. PMCID: PMC1885620. [Download]

647. Wheelock, C.E., S. Goto, B.D. Hammock and J.W. Newman. 2007.  Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics. 3(2):137-145. PMCID: PMC2597807. [Download]

652. Hwang, S.H., H.J. Tsai, J.-Y. Liu, C. Morisseau and B.D. Hammock. 2007.  Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem.  50(16):3825-40. PMCID: PMC2596069. [Download]

653. Endsley, M.P., N. Aggarwal, M.A. Isbell, C.E. Wheelock, B.D. Hammock, J.R. Flack, W.B. Campbell and K. Nithipatikom. 2007. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-lipoxygenase metabolism. Int J Cancer. 121:984-991. PMCID: PMC2565646. [Download]

654. Huang, H., C. Morisseau, J.F. Wang, T. Yang, J.R. Falck, B.D. Hammock and M.-H. Wang. 2007. Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats.  Am J Physiol Renal Physiol. 293:342-349. [Download]

655. Newman, J.W., G.A. Kaysen, B.D. Hammock and G.C. Shearer. 2007. Proteinuria increases oxylipid concentrations in VLDL and HDL, but not LDL particles in the rat. J Lipid Res. 48(8):1792-1800. [Download]

656. Ahn, K.C., S.J. Gee, H.-J. Kim, M. Nichkova, N.A. Lee and B.D. Hammock.  2007. Progress in the development of biosensors for environmental and human monitoring of agrochemicals. In: Symposium 966: Rational Environmental Management of Agrochemicals: Risk Assessment, Monitoring and Remedial Action:  Proceedings of the American Chemical Society Pacifichem 2005, Honolulu, HI (I.R. Kennedy, K. Solomon, S.J. Gee, A. Crossan, S. Wang, F. Sanchez-Bayo eds.), Vol. 966 pp.138-154. ISBN 978-0-8412-7420-4 [Download]

657. Morisseau, C. and B.D. Hammock. 2007. Measurements of soluble epoxide hydrolase (sEH) activity. In: Techniques for analysis of chemical biotransormation.  Current Protocols in Toxicology. (J.S. Bus, L.G. Costa, E. Hodgson, D.A. Lawrence and D.J. Reed eds.), John Wiley & Sons, New Jersey.  4.23.1-4.23.18, August, Supplement 33. [Download]

659. Chiamvimonvat, N., C.-M. Ho, H.-J. Tsai and B.D. Hammock. 2007. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Carviovasc Pharmacol. 50:225-237. [Download]

 

660. Dettmer, K., D. Hanna, P. Whetstone, R. Hansen and B.D. Hammock.  2007. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal Bioanal Chem. 388(8):1643-1651. [Download]

661. Devonshire, A.L., R. Heidari, H.Z. Huang, B.D. Hammock, R.J. Russell and J.G. Oakeshott. 2007. Hydrolysis of individual isomers of fluorogenic pyrethroid analogs by mutant carboxylesterases from Lucilia cuprina. Insect Biochem Mol Biol. 37:891-902. [Download]

663.  Kim, I.H., H.J. Tsai, K. Nishi, T. Kasagami, C. Morisseau and B.D. Hammock. 2007. 1,3-disubstituted ureas functionalized with ether groups and potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties. JMedChem. 50(21):5217-5226. PMCID: PMC 2543935. [Download]

664.Park, E.K., S.K. Mak, D. Kultz and B.D. Hammock. 2007. Evaluation of cytotoxicity attributed to thimerosal on murine and human kidney cells. J Toxicol Environ Health A. 70(24):2092-95. [Download]

665. Fleming, I., A. Rueben, R. Popp, B. Fisslthaler, A. Sander, J. Haendeler, J.R. Flack, C. Morisseau, B.D. Hammock and R. Busse. 2007.

Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells. Arterioscl Throm Vas. 27:2612-18. [Download]

666. Vogel, C.F.A., W. Li, E. Sciullo, J. Newman, B.D. Hammock, J.R. Reader, J. Tuscano and F. Matsumura. 2007. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol. 171:1538-1548. PMCID: PMC2043515. [Download]

667. Hillard, C.J., W.-S.V. Ho, J. Thompson, K.M. Gauthier, C.E. Wheelock, H. Huang and B.D. Hammock. 2007. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. Br J Pharmacol. 152:691-698. PMCID: PMC2190024. [Download]

670. Park, E.K., S.K. Mak, D. Kültz and B.D. Hammock. 2008. Determination of cytotoxicity of nephrotoxins on murine and human kidney cell lines. J Environ Sci Health B. 43:71-74. [Download]

671. Tanaka, H., S.G. Kamita, N.M. Wolf, T.R. Harris, Z. Wu, C. Morisseau and B.D. Hammock. 2008. Transcriptional regulation of the human soluble expoxide hydrolase gene EPHX2. Biochim Biophys Acta. 1779:17-27. PMCID: PMC2699939. [Download]

672. Anderson, P.J., J. Lango, C. Carkeet, A. Britten, B. Kräutler, B.D. Hammock and J.R. Roth. 2008. One pathway can incorporate either adenine or dimethylbenzimidazole as an a-axial ligand of B12 cofactors in Salmonella enterica. J Bacteriol. 190(4):1160-1171. PMCID: PMC2238215. [Download]

675. Aronova, S., K. Wedman, P.A. Aronov, K. Fontes, K. Ramos, B.D. Hammock and T. Powers. 2008. Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab.7:148-158. [Download]

677. Goodfriend, T.L., T.L. Pedersen, R.J. Grekin, B.D. Hammock, D.L. Ball and A. Vollmer. 2007. Heparin, lipoproteins, and oxygenated fatty acids in blood:  A cautionary note. Prostaglandins Leukot Essent Fatty Acids. 77:363-366. PMCID: PMC2705328. [Download]

678. Dreisbach, A.W., J.C. Rice, S. Japa, J.W. Newman, A. Sigel, R.S. Gill, A.E. Hess, A.C. Cemo, J.P. Fonseca, B.D. Hammock, J.J.L. Lertora and L.L. Hamm.  2008. Salt loading increases urinary excretion of linoleic acid diols and triols in healthy human subjects. Hypertension. 51:755-761. [Download]

679. Chen, J., K.C. Ahn, N.A. Gee, M.I. Ahmed, A.J. Duleba, L. Zhao, S.J. Gee, B.D. Hammock and B.L. Lasley. 2008. Triclocarban enhances testosterone action:  A new type of endocrine disruptor? Endocrinology. 149:1173-1179.  PMCID: PMC2275366. [Download]

682. Harris, T.R., P.A. Aronov, P.D. Jones, H. Tanaka, M. Arand and B.D. Hammock. 2008. Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules. Arch Biochem Biophys. 472:139-149. PMCID: PMC2435305. [Download]

683.  Chawengsub, Y., N.T. Aggarwal, K. Nithipatikom, K.M. Gauthier, S. Anjaiah, B.D. Hammock, J.R. Falck and W.B. Campbell. 2008. Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta. Am J Physiol Heart Circ Physiol. 294:1348-1356. [Download]

685.  Wheelock, C.E., J. Forshed, S. Goto, B.D. Hammock and J.W. Newman. 2008. Effects of pyridine exposure upon structural lipid metabolism in Swiss Webster mice. Chem Res Toxicol. 21:583-590. [Download]

686.  Corenblum, M.J., V.E. Wise, K. Georgi, B.D. Hammock, P.A. Doris and M. Fornage. 2008. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.  Hypertension. 51:567-573. [Download]

687.  Morisseau, C., J.W. Newman, C.E. Wheelock, T. Hill III, D. Morin, A.R. Buckpitt and B.D. Hammock. 2008. Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase. Chem Res Toxicol. 21:951-957. [Download]

688.  Monti, J., J. Fischer, S. Paskas, M. Heinig, H. Schulz, C. Gösele, A. Heuser, R. Fischer, C. Schmidt, A. Schirdewan, V. Gross, O. Hummel, H. Maatz, G. Patone, K. Saar, M. Vingron, S.M. Weldon, K. Lindpaintner, B.D. Hammock, K. Rohde, R. Dietz, S.A. Cook, W.-H. Schunck, F.C. Luft and N. Hubner.  2008.  Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.  Nat. Genet. 40:529-537. [Download]

689.  Morisseau, C. and B.D. Hammock.  2008.  Gerry Brooks and epoxide hydrolases:  four decades to a pharmaceutical.  Pest. Manag. Sci. 64:594-609. [Download]

690.  Alihosseini, F., K-S. Ju, J. Lango, B.D. Hammock and G. Sun. 2008. Antibacterial colorants: Characterization of prodiginines and their applications on textile materials. Biotechnol Prog. 24(3):742-747. PMCID: PMC2863012. [Download]

691.  Aronov, P.A., L.M. Hall, K. Dettmer, C.B. Stephensen and B.D. Hammock.  2008.  Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry.  Anal. Bioanal. Chem. 391:1917-1930. [Download]

692. Jiang, H., A.G. Zhu, M. Mamczur, C. Morisseau, B.D. Hammock, J.R. Falck and J.C. McGiff. 2008. Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.  J. Pharmacol. Exp. Ther. 326:330-337. [Download]

693. Wheelock, C.E., M.E. Colvin, J.R. Sanborn and B.D. Hammock.  2008.  Substituted 3-phenylpropenoates and related analogs: electron ionization mass spectral fragmentation and density functional theory calculations.  J. Mass. Spectrom. 43:1053-1062. PMID: 18286670. [Download]

694. Biswal, B.K., C. Morisseau, G. Garen, M.M. Cherney, C. Garen, C. Niu, B.D. Hammock and M.N.G. James. 2008. The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor. J. Mol. Biol. 381:897-912. PMID:18585390. PMCID: PMC2866126. [Download]

698. Harris, T.R., N. Li, N. Chiamvimonvat and B.D. Hammock. 2008. The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy. Congest. Heart Fail. 14:209-224. [Download]

699. Harris, T.R., P.A. Aronov and B.D. Hammock.  2008.  Soluble epoxide hydrolase homologs in Strongylocentrotus purpuratus suggest a gene duplication event and subsequent divergence. DNA Cell Biol. 27(9):467-477. PMID: 18554159. PMCID: PMC2858585. [Download]

702.  Ulu, A., B.B. Davis, H-J. Tsai, I-H. Kim, C. Morisseau, B. Inceoglu, O. Fiehn, B.D. Hammock and R.H. Weiss. 2008. Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein E-knockout mouse model. J. Cardiovasc. Pharmacol. 52:314-323. [Download]

703.  Fife, K.L., YM. Liu, K.R. Scmhmelzer, H-J. Tsai, I-H. Kim, C. Morisseau, B.D. Hammock and D.L. Kroetz. 2008. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J. Pharmacol. Exper. Therap. 327(3):707-715.

[Download]

706.  Inceoglu, B., S.L. Jinks, A. Ulu, C.M. Hegedus, K. Georgi, K.R. Schmelzer, K. Wagner, P.D. Jones, C. Morisseau and B.D. Hammock. 2008. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. PNAS 105(48):18901-18906. [Download]

707.  Keserü, B., E. Barbosa-Sicard, R. Popp, B. Fisslthaler, A. Dietrich, T. Gudermann, B.D. Hammock, J.R. Falck, N. Weissmann, R. Busse and I. Fleming. 2008. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. The FASEB Journal 22:1-10. [Download]

709.  Gross, G.J., K.M. Gauthier, J. Moore, J.R. Falck, B.D. Hammock, W.B. Campbell and K. Nithipatikom. 2008. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. Am. J. Physiol. Heart Circ. Physiol. 294:H2838-H2844. [Download]

710. Olearczyk, J.J., J.E. Quigley, B.C. Mitchell, T. Yamamoto, I-H. Kim, J.W. Newman, A. Luria, B.D. Hammock and J.D. Imig. 2009. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin. Sci. 116:61-70. [Download]

711. Athirakul, K., J.A. Bradbury, J.P. Graves, L.M. DeGraff, J. Ma, Y. Zhao, J.F. Couse, R. Quigley, D.R. Harder, X. Zhao, J.D. Imig, T.L. Pedersen, J.W. Newman, B.D. Hammock, A.J. Conley, K.S. Korach, T.M. Coffman and D.C. Zeldin.  2008.  Increased blood pressure in mice lacking cytochrome P450 2J5. FASEBJ 22:4096-4108. PMCID: PMC2614614. [Download]

712. EnayetAllah, A.E., A. Luria, B. Luo, H-J. Tsai, P. Sura, B.D. Hammock and D.F. Grant. 2008. Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. J Biol Chem. 283(52):36592-98. PMID: 18974052. PMCID: PMC2605982. [Download]

713.  Ai, D., W. Pang, N. Li, M. Xu, P.D. Jones, J. Yang, Y. Zhang, N. Chiamvimonvat, J. Y-J. Shyy, B.D. Hammock and Y. Zhu. 2009. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. PNAS 106(2):564-569. [Download]

714.  Rawal, S., C. Morisseau, B.D. Hammock and A.C. Shivachar. 2009. Differential sub cellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes. J. Neurosci. Res. 87:218-227. PMID: 18711743. [Download]

715.  Revermann, M., E. Barbosa-Sicard, E. Dony, R.T. Schermuly, C. Morisseau, G. Geisslinger, I. Fleming, B.D. Hammock and R.P. Brandes. 2009. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. J. Hypertension 27(2):322-331. [Download]

718.  Liu, J-Y., H-J. Tasi, S.H. Hwang, P.D. Jones, C. Morisseau and B.D. Hammock. 2009. Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation. British Journal of Pharmacology 156(2):284-296. [Download]

719.  Kasagami, T., I-H. Kim, H-J. Tsai, K. Nishi, B.D. Hammock and C. Morisseau. 2009. Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorganic & Medicinal Chemistry Letters 19:1784-1789. [Download]

721.  Xie, Y., Y. Lui, G. Gong, D.H. Smith, F. Yan, A. Rinderspacher, Y. Feng, Z. Zhu, X. Ji, S-X. Deng, L. Branden, D. Vidovic, C. Chung, S. Schürer, C. Morisseau, B.D. Hammock and D. W. Landry. 2009. Discovery of potent non-urea inhibitors of soluble epoxide hydroase. Bioorganic & Medicinal Chemistry Letters 19:2354-2359. PMCID: PMC2738751. [Download]

722. Parrish, A.R., G. Chen, R.C. Burghardt, T. Watanabe, C. Morisseau and B.D. Hammock. 2009. Attenuation of cisplatin nephrotoxicity by an inhibition of soluble epoxide hydrolase. Cell. Biol. Toxicol. 25:217-225. PMID: 18386137. PMCID: PMC3033346. [Download]

<<  < 1 2 3 4 5 6 7 8 > >> 

<<  < 1 2 3 4 5 6 7 8 > >>